Sort
261,768 grants matching “gene therapy”
Engineering microbial social interactions: Towards new anti-biofilm therapies
$2,739,000Joao Xavier · Sloan-Kettering Inst Can Research · DP2 · FY2011 · OD
SAN ANTONIO CANCER INSTITUTE
$2,737,958Tyler J. Curiel · University Of Texas Hlth Science Center · P30 · FY2007 · CA
Spore in Head and Neck Cancer
$2,737,829David Sidransky · Johns Hopkins University · P50 · FY2016 · DE
SPORE IN PROSTATE CANCER
$2,736,840Johns Hopkins University · P50 · FY2005 · CA
Pharmacogenetics of Anticancer Agents Research Group
$2,736,772Mark J Ratain · University Of Chicago · U01 · FY2009 · GM
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
$2,736,269James E Crowe · University Of Texas Med Br Galveston · U19 · FY2019 · AI
Targeting Transcription and Splicing in Cancer
$2,735,999Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2024 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2023 · CA
Mechanisms of inherited neurodegenerative diseases
$2,735,178Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,734,318Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2020 · HL
Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment
$2,734,241David E Fisher · Massachusetts General Hospital · P01 · FY2025 · CA
Genomics of Acute Myelogenous Leukemia
$2,733,974Timothy J Ley · Washington University · P01 · FY2011 · CA
Investigations of Methylmalonic Acidemia and Related Disorders
$2,733,586Charles P Venditti · National Human Genome Research Institute · ZIA · FY2024 · HG
NE-CAT Center for Advanced Macromolecular Crystallography
$2,732,457Steven E Ealick · Cornell University · P41 · FY2014 · GM
Discovery of genetic interactions in cancer
$2,732,082Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · HL
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,728,503Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2021 · HL
Models and Gene Therapies for AAT Deficiency
$2,728,017Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2023 · HL
Models and Gene Therapies for AAT Deficiency
$2,728,017Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · HL
Genes and signals controlling mammalian hematopoiesis.
$2,727,753Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,726,004Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Discovery and validation of novel targets for pharmacotherapy of alcoholism
$2,725,388Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA